The record-high surge of initial public offerings (IPOs) in biopharma last year was especially good news for CEOs of many of those newly public companies.
{iframe}https://www.genengnews.com/a-lists/what-the-top-10-biopharma-ceos-are-making-3/?utm_medium=newsletter&utm_source=GEN%20Daily%20News%20Highlights&utm_content=01&utm_campaign=GEN%20Daily%20News%20Highlights_20190826&oly_enc_id=1673D8247356B7U{/iframe}